A New Audio Interview Featuring Nadav Kidron, CEO of Oramed, is Now at SmallCapVoice.com

Aug. 25, 2010 (Business Wire) — SmallCapVoice.com, Inc. announced today that a new audio interview featuring Oramed Pharmaceuticals Inc. ORMP (http://www.oramed.com), a developer of oral delivery systems, is now available. The interview can be heard at http://smallcapvoice.com/blog/8-24-10-audio-interview-with-oramed-pharmaceuticals-inc-otcbb-ormp.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed’s technology is based on over 25 years of research by top research scientists at Jerusalem’s Hadassah Medical Center. The Company’s corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com.

Oramed Pharmaceuticals Inc.

Tara Horn, +1-646-240-4193
Cell: +972-54-334-4318
tara@oramed.com

SmallCapVoice.com
Stuart T. Smith, 512-267-2430
info@smallcapvoice.com

Source: Business Wire (August 25, 2010 – 8:04 AM EDT)